Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-134-VI
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7494.098
uM
inf
inf
0.9802 0.9802 0.0000 0.0609
-0.0984
0.9748
BT-474
HER2amp
Luminal
Trametinib
MEK
MAPK
9157.012
uM
inf
inf
0.7933 0.7933 0.0000 0.0840
0.4934
0.8641
LY2
HR+
Luminal
AS-252424
PI3K
PI3K
10816.153
uM
inf
inf
0.2645 0.2645 0.0000 0.1603
0.3698
0.7704
SUM225CWN
HER2amp
Basal A
GW843682X
PLK
PLK
10579.139
uM
inf
inf
0.8101 0.8101 0.0000 0.0896
0.0081
1.1260
HCC1395
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7816.017
uM
inf
inf
0.9626 0.9626 0.0000 0.1531
0.2853
1.2318
MCF 10F
NM
-
FTase Inhibitor I
Ftase
MAPK
12254.154
uM
inf
inf
1.0500 1.0500 0.0000 -0.0451
-13.9008
1.6307
SUM225CWN
HER2amp
Basal A
ICRF-193
TOP2
TOP
10579.139
uM
inf
inf
0.6972 0.6972 0.0000 0.1100
-0.0164
1.1260
SUM225CWN
HER2amp
Basal A
ICRF-193
TOP2
TOP
12098.157
uM
inf
inf
0.7855 0.7855 0.0000 0.0460
0.3066
1.3067
HCC1395
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
9254.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.8730
Hs 578T
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7472.098
uM
inf
inf
1.0500 1.0500 0.0000 -0.0197
-0.2479
1.5098
LY2
HR+
Luminal
Sirolimus
MTOR
MTOR
7865.068
uM
inf
inf
-0.1814 -0.1814 0.0000 0.5691
0.4192
1.5516
MCF7
HR+
Luminal
ZM-447439
AURK
AURK
10997.15
uM
inf
inf
0.7198 0.7198 0.0000 0.1640
0.5121
1.4218
21MT-1
HER2amp
-
Dichloroacetate
PDK
PDK
13719.176
uM
inf
inf
0.9233 0.9233 0.0000 0.0596
-0.2426
0.8672
HCC1395
TNBC
Basal B
Dactolisib
PI3K
PI3K
12000.155
uM
inf
inf
0.6675 0.6675 0.0000 0.2919
0.2735
0.8592
HCC1395
TNBC
Basal B
Dactolisib
PI3K
PI3K
12084.155
uM
inf
inf
0.8548 0.8548 0.0000 0.1129
0.4499
1.2955
SUM225CWN
HER2amp
Basal A
JNK-IN-5A
JNK
JNK
12098.144
uM
inf
inf
0.8183 0.8183 0.0000 0.1139
0.5003
1.1959
HCC1395
TNBC
Basal B
Dichloroacetate
PDK
PDK
13538.176
uM
inf
inf
0.8042 0.8042 0.0000 0.1436
0.3146
0.4572
BT-474
HER2amp
Luminal
Dactolisib
PI3K
PI3K
12178.155
uM
inf
inf
0.5782 0.5782 0.0000 0.4091
0.3793
0.8489
HCC1937
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
7453.098
uM
inf
inf
0.9252 0.9252 0.0000 0.0007
0.1372
1.4660
BT-474
HER2amp
Luminal
Disulfiram
Proteasome
Proteasome
13125.174
uM
inf
inf
0.6222 0.6222 0.0000 0.1712
0.3674
0.9685
184B5
NM
Basal
PS-1145
IKK
NFKB
5897.065
uM
inf
inf
0.9561 0.9561 0.0000 0.0500
0.3340
1.2996
MDA-MB-134-VI
HR+
Luminal
Epirubicin
TOP2
TOP
7877.017
uM
inf
inf
1.0500 1.0500 0.0000 0.1618
0.3038
0.6955
HCC1395
TNBC
Basal B
Doxorubicin
TOP2
TOP
7816.007
uM
inf
inf
0.3187 0.3187 0.0000 0.2775
0.3760
1.1536
MDA-MB-361
HER2amp
Luminal
TCS PIM-1 1
Pim kinase
PIM
12379.135
uM
inf
inf
1.0351 1.0351 0.0000 -0.0361
-2.8027
0.4972
SUM225CWN
HER2amp
Basal A
Methotrexate
DHFR
Metabolism
7534.084
uM
inf
inf
0.9557 0.9557 0.0000 0.0114
0.0130
0.8905